Uzbekistan Foreign Restriction Notification: The 10-Day Obligation for Safety Actions Abroad

1. Key takeaways

Registration No. 3752 contains an obligation that is easy to overlook: if a product is prohibited, restricted, or has its labeling changed in another country for safety reasons, this must be notified to the competent authority of Uzbekistan within 10 days. The scope of coverage is broad. It includes withdrawal of the product from a market, Dear Healthcare Professional letters, urgent safety measures, and any regulatory-driven labeling update in any jurisdiction. The 10-day deadline is tighter than comparable requirements in most markets, and the triggering events are far broader than a recall in the narrow sense, which means companies whose trigger lists contain only recalls will systematically miss reportable events. The obligation sits with the manufacturer and the registration certificate holder, so the determination and the notification must both be usable by either party within the same window.

2. Legal basis

3. Expert insights

Insight 1: The triggering events are much broader than a recall. The triggering events listed in registration No. 3752 include withdrawal from the market, Dear Healthcare Professional letters, urgent safety measures, and regulatory-driven labeling updates. This means that a field safety corrective action in the European Union, or a labeling update in the United States, can trigger a notification obligation in Uzbekistan even when the measure is not called a recall anywhere in the process. Companies need to map their global regulatory event taxonomy against the Uzbekistan trigger list, measure by measure, rather than relying on a single recall flag. The notification obligation is therefore best operated as a rule-based check on every global regulatory event, not as a judgment reserved for major recalls.

Insight 2: The qualifying condition is that the action is taken for safety reasons. The phrase for safety reasons is the key test for whether notification is required. Withdrawal from a market for commercial reasons, such as a channel adjustment, falls outside the obligation; withdrawal driven by performance or risk issues falls squarely inside it. Companies should record the reasoning behind each determination in their internal assessment process, so that the decision can be explained later if the authority asks how a given foreign event was evaluated and why it was or was not notified. A short written determination, even one paragraph, is enough to demonstrate that the assessment took place.

Insight 3: The 10-day deadline requires a fast channel between the global organization and the local representative. Similar to the 1-day individual case reporting deadline, the 10-day notification deadline depends on an agreed transfer mechanism between the manufacturer and the representative. The difference is directional: restrictive measures taken in other countries are usually public information, and the representative may learn of them before the manufacturer does, so the channel must work in both directions, with either party able to start the 10-day clock the moment it becomes aware of the measure. Public sources such as authority websites and safety alerts should be part of the monitoring routine on the representative side.

Insight 4: Failure to notify can compound into the post-market surveillance track. Resolution No. 628 gives the Center the power to suspend use, withdraw products from circulation, and order destruction. If a company does not notify a restrictive measure taken abroad and the Center learns of it through other channels, the omission may be treated as concealment, which in turn can trigger harsher disposition measures. The notification itself is far cheaper than the disposition measures it prevents. The cheapest way to avoid that outcome is a complete, timely notification, even for events that initially appear marginal.

4. Practical recommendations

1. Establish a monitoring list of regulatory measures taken in other countries, covering announcements by the regulatory authorities of every market where the product is sold.
2. Record in the internal determination process the reasoning for whether an event qualifies as being for safety reasons, so that the judgment can be substantiated later.
3. Set up a two-way notification mechanism with the local representative, under which either party that becomes aware of a foreign restrictive measure starts the 10-day clock.
4. Include field safety corrective actions in the European Union, recalls and labeling updates in the United States, and similar measures that are not labeled as recalls in the trigger list.
5. Ensure the notification content covers the nature of the measure, the affected batches, the explanation of the cause, and the disposal plan for the Uzbekistan market.

5. Verification checklist

• □ A monitoring list of regulatory measures taken in other countries has been established, covering all markets where the product is sold
• □ The internal determination process records the reasoning for whether an event is for safety reasons
• □ A two-way notification mechanism with the representative is in place, with the 10-day clock started by either party upon awareness
• □ The trigger list includes field safety corrective actions, labeling updates, and other non-recall measures
• □ The notification template covers the nature of the measure, batches, cause, and the local disposal plan
• □ It has been confirmed that failure to notify can trigger disposition measures under Resolution No. 628

Regulatory information verified as of October 29, 2026.

GRZAN provides regulatory support to manufacturers, importers, and authorized representatives seeking medical device registration and post-market compliance in Uzbekistan, including dossier preparation, authorized representative arrangements, vigilance setup, and surveillance readiness. For inquiries, contact info@grzanglobal.com.